Structural changes in the midbrain with aging and Parkinson's disease: an MRI study

Area of Science:

• Neuroimaging
• Neurology
• Radiology

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder affecting motor function.
• Midbrain structural changes, particularly in the substantia nigra, are implicated in PD.
• Accurate MRI-based evaluation of PD-related midbrain alterations is crucial for diagnosis and research.

Purpose of the Study:

• To investigate morphometric differences in midbrain structures between PD patients and healthy controls using T2-weighted MRI.
• To assess age-related variations in these structural differences.
• To explore potential correlations between observed morphometric changes and PD pathology.

Main Methods:

• T2-weighted magnetic resonance imaging (MRI) was used to measure midbrain structures.
• 59 subjects with Parkinson's disease (PD) and 140 age- and gender-matched healthy controls participated.
• Key measurements included the maximum distance of the substantia nigra (SND) and the average distance from the substantia nigra to the red nucleus (SNRND).

Main Results:

• In PD patients aged 70 or less, a significant increase in SND and a significant decrease in SNRND were observed compared to controls.
• These morphometric changes in younger PD patients may suggest increased iron concentration and neuronal loss.
• No significant differences in midbrain structures were detected between PD patients and controls in the group older than 70.

Conclusions:

• Morphometric analysis of midbrain structures using T2-weighted MRI can differentiate younger PD patients from healthy controls.
• Age appears to influence the detectability of PD-related midbrain structural alterations via MRI.
• These findings offer valuable insights for interpreting conventional MR images in the context of Parkinson's disease evaluation.